Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Iranian Journal of Pharmaceutical Research : IJPR|September 5, 2022
How Do Iranian Stakeholders Think About Pharmaceutical Managed Entry Agreements?Nikta Shobeiri, Farzad Peiravian, Nazila YousefiHealth Science Reports|September 12, 2025
Economic Burden of Diseases Caused by Air Pollution in Iran: A Cross-Sectional StudyNikta Shobeiri, Amin Adel, Asma Rashki KemmakThe Protein Journal|November 8, 2025
Strategic Approaches for Overcoming Peptide and Protein Drug LimitationsMahsa Cheshomi, Nikta Shobeiri, Amineh Sadat Tajani, et al.BMC Pulmonary Medicine|November 5, 2023
Evaluating the affordability of asthma, chronic obstructive pulmonary disease, and cystic fibrosis medicines in a middle-income countryMahdieh Fathi, Najmeh Moradi, Nazila Yousefi, et al.European Journal of Medicinal Chemistry|March 15, 2016
Synthesis and biological evaluation of quinoline analogues of flavones as potential anticancer agents and tubulin polymerization inhibitorsNikta Shobeiri, Maryam Rashedi, Fatemeh Mosaffa, et al.Expert Review of Pharmacoeconomics & Outcomes Research|August 6, 2024
Cost-effectiveness analysis of tofacitinib for the treatment of moderate to severe rheumatoid arthritis: a systematic review and meta-analysisBehzad Fatemi, Neda Yaghoubi, Nikta Shobeiri, et al.Iranian Journal of Pharmaceutical Research : IJPR|March 19, 2020
Country Pharmaceutical Situation on Access, Quality, and Rational Use of Medicines: An Evidence from a middle-income countryHossein Minaei, Mohammad Peikanpour, Nazila Yousefi, et al.Journal of Diabetes and Metabolic Disorders|November 20, 2025
Association between vitamin D deficiency and general and abdominal obesity in older adults: insights from baseline data of the Birjand Longitudinal Aging Study (BLAS)Mehdi Varmaghani, Amirmohammad Tajik, Mehraneh Movahedi Aliabadi, et al.Pageof 1